戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ated with increased mRNA expression of VASP (vasodilator-stimulated phosphoprotein).
2 e highly related to Enabled as well as VASP (Vasodilator-Stimulated Phosphoprotein).
3  as an established protein substrate of PKG (vasodilator-stimulated phosphoprotein).
4  activation of cofilin 1 and inactivation of vasodilator-stimulated phosphoprotein.
5 al nitric oxide synthase, and phosphorylated vasodilator-stimulated phosphoprotein.
6 lls and increases the phosphorylation of the vasodilator-stimulated phosphoprotein.
7 ne of these clones was found to encode VASP (vasodilator-stimulated phosphoprotein), a previously ide
8 ICAM-1, and decreased phosphorylation of the vasodilator-stimulated phosphoprotein, a marker for nitr
9  of isoproterenol-induced phosphorylation of vasodilator-stimulated phosphoprotein, a membrane cytosk
10                       Zyxin in turn recruits vasodilator-stimulated phosphoprotein, a regulator of ac
11 actin and associated cellular proteins, like vasodilator-stimulated phosphoprotein, adjacent to the a
12 ficantly reduced phosphorylation of platelet vasodilator-stimulated phosphoprotein, an indicator of N
13 3 exposure also led to the redistribution of vasodilator-stimulated phosphoprotein, an NO regulated p
14 A2beta-null cells potentiates Ang II-induced vasodilator-stimulated phosphoprotein and Akt phosphoryl
15 ost actin-regulatory layer containing zyxin, vasodilator-stimulated phosphoprotein and alpha-actinin.
16  partners alpha-actinin and p130Cas, but not vasodilator-stimulated phosphoprotein and cysteine-rich
17 ted exaggerated levels of phosphorylation of vasodilator-stimulated phosphoprotein and extracellular
18 eton-associated proteins including mammalian vasodilator-stimulated phosphoprotein and murine Enabled
19 thromboxane A(2) significantly decreased and vasodilator-stimulated phosphoprotein and nitric oxide i
20 ostanes, and thromboxane A(2), and increased vasodilator-stimulated phosphoprotein and nitric oxide.
21 tivate PKG as measured by phosphorylation of vasodilator-stimulated phosphoprotein, and by in vitro k
22 Enabled, phosphorylated (p)-cortactin, and p-vasodilator-stimulated phosphoprotein, and increased act
23 sured by light transmittance aggregometry or vasodilator-stimulated phosphoprotein assays, was numeri
24  associated with fascin along the length and vasodilator-stimulated phosphoprotein at the tip.
25 elin-1 may involve Ca(2+), cytoskeleton, and vasodilator-stimulated phosphoprotein changes mediated b
26 encies in actin cytoskeletal organization of vasodilator-stimulated phosphoprotein-containing lamelli
27                                  The Enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) family
28                           Drosophila enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) homolog
29                                      Enabled/Vasodilator-stimulated phosphoprotein (Ena/VASP) protein
30                                      Enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) protein
31                              We used Enabled/vasodilator-stimulated phosphoprotein (Ena/VASP)-deficie
32 pendent exocytosis of the late endosome in a vasodilator-stimulated phosphoprotein envelope.
33 ruits host cell Arp2/3 complexes and enabled/vasodilator-stimulated phosphoprotein family members to
34 ave examined the function of a member of the vasodilator-stimulated phosphoprotein family of proteins
35 equently was shown to be a member of the Ena/vasodilator-stimulated phosphoprotein family of proteins
36 eletal regulatory proteins of the Mena/VASP (vasodilator-stimulated phosphoprotein) family.
37 ion occurs because of associations involving vasodilator-stimulated phosphoprotein, focal adhesion ki
38 in in response to S-nitrosylation, including vasodilator-stimulated phosphoprotein, focal adhesion ki
39 ion occurs because of associations involving vasodilator-stimulated phosphoprotein, focal adhesion ki
40 es the rapid zyxin-dependent mobilization of vasodilator-stimulated phosphoprotein from focal adhesio
41 nitiation was the gradual coalescence of GFP-vasodilator-stimulated phosphoprotein (GFP-VASP) fluores
42 tions between the C-terminal EVH1 (Ena/VASP [vasodilator-stimulated phosphoprotein] homology domain 1
43 sphate receptor blockade was assessed by the vasodilator-stimulated phosphoprotein index.
44 hidonoyl glycerol-induced phosphorylation of vasodilator-stimulated phosphoprotein is mediated by cAM
45      Pharmacodynamic assessments measured by vasodilator-stimulated phosphoprotein, light transmittan
46 different assays, including VerifyNow P2Y12, vasodilator-stimulated phosphoprotein, light transmittan
47 TPase, peroxisomal farnesylated protein, Ena/vasodilator-stimulated phosphoprotein-like protein, alph
48 let Nox2, Rac1, p47(phox), protein kinase C, vasodilator-stimulated phosphoprotein, nitric oxide, and
49 n) and biochemically (the phosphorylation of vasodilator-stimulated phosphoprotein, or P-VASP).
50              The APC was not correlated with vasodilator-stimulated phosphoprotein (p = 0.16).
51                                 On-treatment vasodilator stimulated phosphoprotein P2Y(12) platelet r
52              Pharmacodynamic end-points were vasodilator-stimulated phosphoprotein P2Y(12) platelet r
53 d or prevented by postsynaptic expression of vasodilator-stimulated phosphoprotein phospho-mimetic or
54 al cyclic adenosine monophosphate (cAMP) and vasodilator-stimulated phosphoprotein phosphorylation (V
55                                Inhibition of vasodilator-stimulated phosphoprotein phosphorylation an
56 d IPA was lower and P2Y12 reaction units and vasodilator-stimulated phosphoprotein phosphorylation an
57                  In contrast, Ang II-induced vasodilator-stimulated phosphoprotein phosphorylation an
58 (P2Y12 assay) and platelet reactivity index (vasodilator-stimulated phosphoprotein phosphorylation as
59 PD was assessed by using VerifyNow P2Y12 and vasodilator-stimulated phosphoprotein phosphorylation as
60 d significant positive correlations with the vasodilator-stimulated phosphoprotein phosphorylation as
61 denosine diphosphate, VerifyNow P2Y(12), and vasodilator-stimulated phosphoprotein phosphorylation as
62  5 and 20 mumol/l and arachidonic acid), and vasodilator-stimulated phosphoprotein phosphorylation as
63 to dense granules, as confirmed by increased vasodilator-stimulated phosphoprotein phosphorylation in
64 e aggregometry, VerifyNow P2Y(12) assay, and vasodilator-stimulated phosphoprotein phosphorylation in
65 GP) IIb/IIIa after stimulation with ADP, and vasodilator-stimulated phosphoprotein phosphorylation le
66  and PKA, as determined by Rap1 activity and vasodilator-stimulated phosphoprotein phosphorylation, r
67 atment of the cells with kinetics similar to vasodilator-stimulated phosphoprotein phosphorylation.
68  h using light transmission aggregometry and vasodilator-stimulated phosphoprotein phosphorylation.
69  production, cGMP synthesis, and PKG-induced vasodilator-stimulated phosphoprotein phosphorylation.
70 e aggregometry, VerifyNow P2Y(12) assay, and vasodilator-stimulated phosphoprotein phosphorylation.
71 ith different agonists as well as changes in vasodilator-stimulated phosphoprotein platelet reactivit
72 esidual platelet aggregation, p = 0.005) and vasodilator-stimulated phosphoprotein platelet reactivit
73 icantly reduced the effect of clopidogrel on vasodilator-stimulated phosphoprotein platelet reactivit
74 y Artery Bypass Graft (APTITUDE-CABG) study, vasodilator-stimulated phosphoprotein-platelet reactivit
75 e shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin
76 the actin-associated proteins alpha-actinin, vasodilator-stimulated phosphoprotein, profilin, Eps8, a
77 ogaster Enabled (Ena) is a member of the Ena/vasodilator-stimulated phosphoprotein protein family, wh
78 nteraction with Ena/VASP (Drosophila Enabled/Vasodilator-stimulated phosphoprotein) proteins.
79 1) binding domains of Lpd and the host VASP (vasodilator-stimulated phosphoprotein) recruited to the
80 tream effects, increasing phosphorylation of vasodilator-stimulated phosphoprotein, reducing DNA synt
81 s of the actin-binding protein, cofilin, and vasodilator-stimulated phosphoprotein-regulating conform
82 21680 showed 1) increased phosphorylation of vasodilator-stimulated phosphoprotein that was blocked b
83 l proteins, including the Arp2/3 complex and vasodilator-stimulated phosphoprotein, throughout the ac
84 focal adhesion proteins, including zyxin and vasodilator-stimulated phosphoprotein, undergo retrograd
85  prevented NO-induced phosphorylation of the vasodilator-stimulated phosphoprotein VASP both when NO
86  decrease in PKG-mediated phosphorylation of vasodilator-stimulated phosphoprotein (VASP) and a subse
87                                              Vasodilator-stimulated phosphoprotein (VASP) and Ena-VAS
88 RRs were directly responsible for binding of vasodilator-stimulated phosphoprotein (VASP) and for the
89 d in a time-dependent loss of phosphorylated vasodilator-stimulated phosphoprotein (VASP) and signifi
90 ofilin-actin by the last poly-Pro segment of vasodilator-stimulated phosphoprotein (VASP) and the bin
91 toskeletal substrates for PKA, including the vasodilator-stimulated phosphoprotein (VASP) and the pro
92              Molecularly, we have identified vasodilator-stimulated phosphoprotein (VASP) as a new mi
93                                              Vasodilator-stimulated phosphoprotein (VASP) associates
94                                              Vasodilator-stimulated phosphoprotein (VASP) can catalyz
95                               Members of the vasodilator-stimulated phosphoprotein (VASP) family are
96 le zyxin sequences capable of binding to Ena/vasodilator-stimulated phosphoprotein (VASP) family memb
97 associates with members of the Enabled (Ena)/vasodilator-stimulated phosphoprotein (VASP) family of c
98  more recently, as a member of the Ena/human vasodilator-stimulated phosphoprotein (VASP) family of p
99 (SH3), WW, GYF, and Drosophila enabled (Ena)/vasodilator-stimulated phosphoprotein (VASP) homology 1
100 oncentrations nor induced phosphorylation of vasodilator-stimulated phosphoprotein (VASP) in washed h
101                                              Vasodilator-stimulated phosphoprotein (VASP) is a major
102                                              Vasodilator-stimulated phosphoprotein (VASP) is active i
103                                              Vasodilator-stimulated phosphoprotein (VASP) is involved
104  (NO) synthase (eNOS)/protein kinase G (PKG)/vasodilator-stimulated phosphoprotein (VASP) pathway.
105                                          The vasodilator-stimulated phosphoprotein (VASP) plays an im
106                                      The Ena/vasodilator-stimulated phosphoprotein (VASP) protein fam
107                                Enabled (Ena)/vasodilator-stimulated phosphoprotein (VASP) proteins re
108                                          Ena/vasodilator-stimulated phosphoprotein (VASP) proteins re
109 rovide genetic and biochemical evidence that vasodilator-stimulated phosphoprotein (VASP) recruitment
110 ow the multifunctional actin-binding protein vasodilator-stimulated phosphoprotein (VASP) regulates t
111 n this study, we sought to determine whether vasodilator-stimulated phosphoprotein (VASP) signaling i
112 us sequence = FE(D)FPPPPTD(E)E(D)] to tether vasodilator-stimulated phosphoprotein (VASP) to the bact
113 e L. monocytogenes strains unable to recruit vasodilator-stimulated phosphoprotein (VASP) to their su
114 ctin (F-actin) and of the signaling molecule vasodilator-stimulated phosphoprotein (VASP) was measure
115 rylation and intracellular redistribution of vasodilator-stimulated phosphoprotein (VASP), a critical
116 were induced by macrophage overexpression of vasodilator-stimulated phosphoprotein (VASP), a key down
117                         Targeted deletion of vasodilator-stimulated phosphoprotein (VASP), a key down
118 hances the phosphorylation at Ser-239 of the vasodilator-stimulated phosphoprotein (VASP), a major su
119  expression and phosphorylation state of the vasodilator-stimulated phosphoprotein (VASP), a membrane
120 by AE33 shares similarity with the mammalian vasodilator-stimulated phosphoprotein (VASP), a substrat
121   Microsequencing identified this protein as vasodilator-stimulated phosphoprotein (VASP), an actin b
122 that the actin polymerizing proteins Arp2/3, vasodilator-stimulated phosphoprotein (VASP), and neural
123 lation of actin-based propulsion require the vasodilator-stimulated phosphoprotein (VASP), which bind
124 the PKG-GFP fusion proteins colocalized with vasodilator-stimulated phosphoprotein (VASP).
125 a actin-based motility is the involvement of vasodilator-stimulated phosphoprotein (VASP).
126 rated that vinculin p90 binds to IcsA and to vasodilator-stimulated phosphoprotein (VASP).
127 ase G (PKG) and its downstream effector, the vasodilator-stimulated phosphoprotein (VASP).
128 sphorylation of the actin regulatory protein vasodilator-stimulated phosphoprotein (VASP).
129 red by phosphorylation of the key cGK target vasodilator-stimulated phosphoprotein (VASP).
130 oteins including the Ena/VASP family member, vasodilator-stimulated phosphoprotein (VASP); however, a
131              Platelet function test results (vasodilator-stimulated phosphoprotein [VASP] phosphoryla
132 lls transfected with the cGKII phosphorylate vasodilator-stimulated phosphoprotein, VASP, after cGMP
133                           Phosphorylation of vasodilator-stimulated phosphoprotein was impaired in HO
134  Ras homolog gene family member A (RhoA) and vasodilator-stimulated phosphoprotein was increased in r
135 k was released, whereas a novel complex with vasodilator-stimulated phosphoprotein was stimulated.
136 aramagnetic resonance and phosphorylation of vasodilator-stimulated phosphoprotein were determined.
137 rotein kinase A (PKA), and the PKA substrate vasodilator-stimulated phosphoprotein were involved in A
138                    The changes in ICAM-1 and vasodilator-stimulated phosphoprotein were recapitulated
139                           Phosphorylation of vasodilator-stimulated phosphoprotein, which is regulate

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top